WANJIA GROUP (00401) announced its unaudited interim results for the six months ended September 30, 2025. The company recorded revenue of HK$85.706 million, representing a 2.4% year-on-year increase. However, it reported a loss attributable to shareholders of HK$712,000, compared to a profit of HK$1.256 million in the same period last year. Basic loss per share stood at HK$0.00127. The revenue growth was primarily driven by increased income from the hemodialysis business segment.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.